These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study. Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044 [TBL] [Abstract][Full Text] [Related]
6. microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP). Tatura R; Buchholz M; Dickson DW; van Swieten J; McLean C; Höglinger G; Müller U Neurogenetics; 2016 Jul; 17(3):165-71. PubMed ID: 27052995 [TBL] [Abstract][Full Text] [Related]
7. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy. Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review. Bougea A Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454322 [No Abstract] [Full Text] [Related]
9. Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy. Ramaswamy P; Christopher R; Kumar Pal P; Debnath M; Yadav R Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626359 [TBL] [Abstract][Full Text] [Related]
10. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related]
12. The diagnosis of progressive supranuclear palsy: current opinions and challenges. Ali F; Josephs K Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389 [TBL] [Abstract][Full Text] [Related]
13. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma. Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417 [TBL] [Abstract][Full Text] [Related]
14. Neurofilament Light Chain Levels in Frontotemporal Dementia and Progressive Supranuclear Palsy: A Systematic Review. Bendstrup N; Hejl AM; Salvesen L J Alzheimers Dis; 2022; 87(1):131-140. PubMed ID: 35275542 [TBL] [Abstract][Full Text] [Related]
15. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445 [TBL] [Abstract][Full Text] [Related]